Ireland - English - HPRA (Health Products Regulatory Authority)

santen oy - tafluprost - eye drops, solution - 15 microgram(s)/millilitre - tafluprost

Australia - English - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - mesalazine, quantity: 1000 mg - enema - excipient ingredients: disodium edetate; sodium acetate; purified water; sodium metabisulfite; hydrochloric acid - for the treatment of ulcerative proctosigmoiditis and/or treatment of left-sided ulcerative colitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - propofol, quantity: 10 mg/ml - injection, emulsion - excipient ingredients: egg lecithin; sodium hydroxide; disodium edetate; glycerol; water for injections; soya oil - diprivan is a short-acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and in children aged three years and older. diprivan has no analgesic properties. although the safety and efficacy of diprivan in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. diprivan may also be used in adults for sedation of ventilated patients receiving intensive care. diprivan may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures. indications as at 4 november 2004: induction of general anaesthesia in children and adults. diprivan is a short-acting intravenous anaesthetic agent suitable for induction of general anaesthesia in adults and children aged one month and older. maintenance of general anaesthesia in children and adults. diprivan is a short acting intravenous anaesthetic agent suitable for maintenance of general anaesthesia in adults and children aged 3 years and older. diprivan may also be used for maintenance of general anaesthesia in children aged from one month to 3 years for procedures not exceeding 60 minutes, unless alternative anaesthetic agents should be avoided. diprivan has no analgesic properties. sedation during intensive care in adults. diprivan may also be used in adults for sedation of ventilated patients receiving intensive care. conscious sedation for surgical and diagnostic procedures in adults. diprivan may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures.

Australia - English - Department of Health (Therapeutic Goods Administration)

specialites septodont pty ltd - lidocaine hydrochloride monohydrate, quantity: 20 mg/ml; adrenaline (epinephrine), quantity: 12.5 microgram/ml (equivalent: adrenaline (epinephrine) acid tartrate, qty 22.8 microgram/ml) - injection, solution - excipient ingredients: sodium chloride; potassium metabisulfite; disodium edetate; sodium hydroxide; water for injections - indications as at 17 july 2003: lignocaine solutions are indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques. lignocaine solutions with adrenaline are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.

Australia - English - Department of Health (Therapeutic Goods Administration)

specialites septodont pty ltd - lidocaine hydrochloride monohydrate, quantity: 20 mg/ml; adrenaline (epinephrine), quantity: 12.5 microgram/ml (equivalent: adrenaline (epinephrine) acid tartrate, qty 22.8 microgram/ml) - injection, solution - excipient ingredients: sodium chloride; potassium metabisulfite; disodium edetate; water for injections; sodium hydroxide - indications as at 17 july 2003: lignocaine solutions are indicated for the production of local anaesthesia in routine procedures and oral surgery by means of infiltration and nerve block techniques. lignocaine solutions with adrenaline are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - mesna, quantity: 100 mg/ml - injection, concentrated - excipient ingredients: disodium edetate; sodium hydroxide; water for injections - for the reduction and prevention of urinary tract toxicity (haemorrhagic cystitis) of oxazaphosphorines (see adverse effects section of the cyclophosphamide and ifosfamide product information).

Ireland - English - HPRA (Health Products Regulatory Authority)

reckitt benckiser ireland ltd - hamamelis water; naphazoline hydrochloride - eye drops, solution - 12.5 %w/v + 0.01 percent weight/volume - sympathomimetics used as decongestants; naphazoline, combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

leo pharma a/s - azelaic acid - gel - 15 percent - other anti-acne preparations for topical use; azelaic acid

Ireland - English - HPRA (Health Products Regulatory Authority)

baxter holding b.v. - magnesium chloride hexahydrate; sodium chloride; sodium hydrogen carbonate; potassium chloride; disodium phosphate dihydrate - solution for haemodialysis/haemofiltration - hemofiltrates

Ireland - English - HPRA (Health Products Regulatory Authority)

santen oy - tafluprost; timolol maleate - eye drops, solution - 15/5 microgram(s)/millilitre - timolol, combinations